文献速递角膜与眼表疾病

cRGD偶联胆红素纳米颗粒通过激活PINK1介导的线粒体自噬缓解干眼病

cRGD-Conjugated Bilirubin Nanoparticles Alleviate Dry Eye Disease Via Activating the PINK1-Mediated Mitophagy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

本研究评估cRGD偶联胆红素纳米颗粒(cNPs@BR)在干眼病中的细胞保护作用及机制。体外实验显示cNPs@BR可减轻氧化应激和炎症反应,小鼠干眼模型中被证实能保护眼表上皮并恢复结膜杯状细胞,机制与激活PINK1介导的线粒体自噬相关。

要点

  • cRGD肽延长纳米颗粒在人角膜上皮细胞上的滞留时间并提高细胞摄取效率。
  • 20 µM cNPs@BR预处理在LPS刺激的RAW264.7细胞和高渗人角膜上皮细胞中减轻氧化应激和炎症反应。
  • cNPs@BR通过激活PINK1介导的线粒体自噬保护眼表上皮并恢复结膜杯状细胞。

核心结论

  • cNPs@BR通过激活PINK1介导的线粒体自噬抑制眼表上皮的氧化应激和炎症反应并恢复杯状细胞。

研究设计与样本

  • 体外研究:在人角膜上皮细胞(HCECs)和LPS刺激的RAW264.7细胞中评估cNPs@BR的细胞摄取、抗炎和抗氧化应激作用。
  • 动物实验:在0.2% BAC诱导的干眼病小鼠模型中评估cNPs@BR对眼表屏障功能、泪液分泌和杯状细胞数量的影响。
  • 机制探索:通过RNA测序和RNA干扰研究cNPs@BR治疗干眼病的作用机制。

主要发现

  • cRGD肽延长纳米颗粒在HCECs上的滞留时间并增强细胞摄取效率。
  • 在两种细胞模型中,20 µM cNPs@BR预处理降低细胞内活性氧(ROS)水平及NOX4和4-HNE表达,同时促进HO-1和核Nrf2水平。
  • cNPs@BR通过抑制NF-κB p65核转位、降低iNOS表达及减少IL-1β、IL-6和TNF-α分泌来减轻炎症反应。
  • 在小鼠干眼病模型中,cNPs@BR通过激活PINK1介导的线粒体自噬保护眼表上皮免受氧化应激和炎症损伤并恢复结膜杯状细胞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the cytoprotective effect and the mechanism of cRGD-conjugated bilirubin nanoparticles (cNPs@BR) in dry eye disease (DED). METHODS: The binding capacity and cellular uptake of cNPs@BR in human corneal epithelial cells (HCECs) were assessed by immunofluorescence. The anti-inflammation and anti-oxidative stress effects of cNPs@BR were determined by flow cytometry, immunofluorescence, Western blot, chromatin immunoprecipitation (ChIP), and ELISA assay in LPS-stimulated RAW264.7 cells and hypertonic HCECs. The function of ocular surface barrier, tear production, and the number of goblet cells after cNPs@BR treatment were further assessed by fluorescein sodium staining, phenol red cotton threads, quantitative PCR (qPCR), hematoxylin and eosin (H&E) staining, and Periodic Acid-Schiff (PAS) staining in a 0.2% BAC-induced DED mouse model. Furthermore, the mechanism of cNPs@BR in treating DED was explored by RNA sequencing and RNA interference. RESULTS: The cRGD peptide prolonged the retention time of nanoparticles on HCECs and enhanced the cellular uptake efficiency. In both cell models, 20 µM cNPs@BR pretreatment ameliorated oxidative stress by decreasing the intracellular reactive oxygen species (ROS) levels and the expression of NOX4 and 4-HNE, while promoting HO-1 and nuclear Nrf2 levels. Moreover, cNPs@BR alleviated the inflammatory response by inhibiting NF-κB p65 nuclear translocation and decreasing the expression of iNOS and the secretion of IL-1β, IL-6, and TNF-α. In addition, cNPs@BR protected ocular surface epithelium against oxidative stress and inflammation and restored conjunctival goblet cells in the mouse model of DED by activating PINK1-mediated mitophagy. CONCLUSIONS: The cNPs@BR suppressed oxidative stress and inflammatory response in the ocular surface epithelium and restored goblet cells by activating PINK1-mediated mitophagy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Huang Y, Wang L, Jin H, et al. cRGD-Conjugated Bilirubin Nanoparticles Alleviate Dry Eye Disease Via Activating the PINK1-Mediated Mitophagy. Invest Ophthalmol Vis Sci. 2024. PMID: 39589348. doi:10.1167/iovs.65.13.55

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。